Endo Pharmaceuticals, Inc. 2023-04-05 Health serious FDA
Health · FDA · Recall #FDA-D-0475-2023
Calcitonin Salmon Nasal Spray, USP, 2200 International Units per mL corresponding to 200… Recall
Issued April 5, 2023 · Endo Pharmaceuticals, Inc.
In April 2023, Endo Pharmaceuticals, Inc. recalled the Calcitonin Salmon Nasal Spray, USP, 2200 International Units per mL corresponding to 200…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Failed Impurities/Degradation Specifications and Subpotent Drug: High Out of Specification results for a known and unknown impurity as well as low Out of Specification results for assay.
What you should do
- 1 Stop using Calcitonin Salmon Nasal Spray, USP, 2200 International Units per mL corresponding to 200… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Endo Pharmaceuticals, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Endo Pharmaceuticals, Inc.
- Category
- Health
- Recall date
- April 5, 2023
- Units affected
- Not reported
- Sold at
- Nationwide in the USA and Puerto Rico
- Recall number
- FDA-D-0475-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Endo Pharmaceuticals, Inc. has 1 recall in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.